BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18475186)

  • 1. Induction immunosuppression with thymoglobulin and rituximab in intestinal and multivisceral transplantation.
    Vianna RM; Mangus RS; Fridell JA; Weigman S; Kazimi M; Tector J
    Transplantation; 2008 May; 85(9):1290-3. PubMed ID: 18475186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: improved outcomes with new outlooks.
    Abu-Elmagd KM; Mazariegos G; Costa G; Soltys K; Bond G; Sindhi R; Green M; Jaffe R; Wu T; Koritsky D; Matarese L; Schuster B; Martin L; Dvorchik I; Nalesnik MA
    Transplantation; 2009 Oct; 88(7):926-34. PubMed ID: 19935465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period.
    Zanfi C; Lauro A; Cescon M; Dazzi A; Ercolani G; Grazi GL; Zanello M; Vivarelli M; Del Gaudio M; Ravaioli M; Cucchetti A; Vetrone G; Tuci F; Di Gioia P; Lazzarotto T; D'Errico A; Bagni A; Faenza S; Siniscalchi A; Pironi L; Pinna AD
    Transplant Proc; 2010; 42(1):35-8. PubMed ID: 20172276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients.
    Berney T; Delis S; Kato T; Nishida S; Mittal NK; Madariaga J; Levi D; Nery JR; Cirocco RE; Gelman B; Ruiz P; Tzakis AG
    Transplantation; 2002 Oct; 74(7):1000-6. PubMed ID: 12394845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction regimens and post-transplantation lymphoproliferative disorder after pediatric intestinal transplantation: Single-center experience.
    Devine K; Ranganathan S; Mazariegos G; Bond G; Soltys K; Ganoza A; Sun Q; Sindhi R
    Pediatr Transplant; 2020 Aug; 24(5):e13723. PubMed ID: 32424963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up.
    Mangus RS; Fridell JA; Vianna RM; Kwo PY; Chen J; Tector AJ
    Liver Transpl; 2012 Jul; 18(7):786-95. PubMed ID: 22237953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).
    Cai J
    Clin Transpl; 2009; ():83-101. PubMed ID: 20524278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
    Farney AC; Doares W; Rogers J; Singh R; Hartmann E; Hart L; Ashcraft E; Reeves-Daniels A; Gautreaux M; Iskandar SS; Moore P; Adams PL; Stratta RJ
    Transplantation; 2009 Sep; 88(6):810-9. PubMed ID: 19920781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal and multivisceral transplantation at the University of Miami.
    Selvaggi G; Nishida S; Levi D; Moon J; Island E; Tekin A; Weppler D; Tzakis A
    Clin Transpl; 2009; ():211-7. PubMed ID: 20524286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal and multivisceral transplantation immunosuppression protocols--literature review.
    Trevizol AP; David AI; Dias ER; Mantovani D; Pécora R; D'Albuquerque LA
    Transplant Proc; 2012 Oct; 44(8):2445-8. PubMed ID: 23026616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined induction therapy with rabbit antithymocyte globulin and rituximab in highly sensitized renal recipients.
    Laftavi MR; Pankewycz O; Feng L; Said M; Patel S
    Immunol Invest; 2015; 44(4):373-84. PubMed ID: 25942348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy.
    Eason JD; Nair S; Cohen AJ; Blazek JL; Loss GE
    Transplantation; 2003 Apr; 75(8):1396-9. PubMed ID: 12717237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction immunosuppression with rabbit antithymocyte globulin in pediatric liver transplantation.
    Shah A; Agarwal A; Mangus R; Lim J; Fridell J; Vianna R; Tector AJ
    Liver Transpl; 2006 Aug; 12(8):1210-4. PubMed ID: 16868953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of More Intensive Induction With Less Acute Rejection Following Intestinal Transplantation: Results of 445 Consecutive Cases From a Single Center.
    Vianna R; Farag A; Gaynor JJ; Selvaggi G; Tekin A; Garcia J; Beduschi T
    Transplantation; 2020 Oct; 104(10):2166-2178. PubMed ID: 31929425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabbit antithymocyte globulin induction and risk of post-transplant lymphoproliferative disease in adult and pediatric solid organ transplantation: An update.
    Hertig A; Zuckermann A
    Transpl Immunol; 2015 Jun; 32(3):179-87. PubMed ID: 25936966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Campath-1H immunosuppressive therapy reduces incidence and intensity of acute rejection in intestinal and multivisceral transplantation.
    Garcia M; Weppler D; Mittal N; Nishida S; Kato T; Tzakis A; Ruiz P
    Transplant Proc; 2004 Mar; 36(2):323-4. PubMed ID: 15050146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-seven consecutive intestinal and multivisceral transplants in adult patients: a 4-year clinical experience.
    Lauro A; Di Benedetto F; Masetti M; Cautero N; Ercolani G; Vivarelli M; De Ruvo N; Cescon M; Varotti G; Dazzi A; Siniscalchi A; Begliomini B; Pironi L; Di Simone M; D'Errico A; Ramacciato G; Grazi G; Pinna AD
    Transplant Proc; 2005; 37(6):2679-81. PubMed ID: 16182782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of intestinal and multivisceral transplantation in adult patients: Italian experience.
    Lauro A; Dazzi A; Ercolani G; Cescon M; D'Errico A; Di Simone M; Grazi GL; Vivarelli M; Varotti G; De Ruvo N; Masetti M; Cautero N; Di Benedetto F; Siniscalchi A; Begliomini B; Lazzarotto T; Faenza S; Pironi L; Pinna AD
    Transplant Proc; 2006; 38(6):1696-8. PubMed ID: 16908252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.